Serplulimab - CAS 2231029-82-4

Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.

PD-1/PD-L1, COX, STAT, Akt

Cell Cycle/Checkpoint, Stem Cells, Immunology/Inflammation, Apoptosis, Cytoskeletal Signaling, PI3K/Akt/mTOR signaling, JAK/STAT signaling, Neuroscience

2230943

>95%

-20°C

Ice Packs

Inhibitory Antibodies